Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2004
09/09/2004US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
09/09/2004US20040176409 treating or preventing a metabolic disorder or an inflammatory condition; modulate the PPAR gamma receptor; diagnosis and treatment of: type II diabetes, hypercholesterolemia, and inflammatory disorders
09/09/2004US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation
09/09/2004US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
09/09/2004US20040176374 Arylsulfonamides as antiviral agents
09/09/2004US20040176364 Aryl substituted thiazinidinones and the use thereof
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants
09/09/2004US20040176355 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment
09/09/2004DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments
09/08/2004EP1454907A1 Quninazoline and pyridopyrmidine derivatives
09/08/2004EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia
09/08/2004EP1453817A1 Thiazole derivatives with fungicidal activity
09/08/2004EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453515A2 Method to treat cystic fibrosis
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004EP1289950B1 Serine protease inhibitors
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP1084114B1 Isothiazole derivatives useful as anticancer agents
09/08/2004EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
09/08/2004EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors
09/08/2004CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes
09/08/2004CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
09/08/2004CN1527827A Therapeutic heterocyclic compounds
09/08/2004CN1527819A Novel heterocyclic compound and medicinal use thereof
09/08/2004CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1165534C Heterocyclyl amino methyloxazolidinones as antibacterials
09/08/2004CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors
09/07/2004US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives
09/07/2004US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents
09/07/2004US6787561 Benzimidazole compounds
09/07/2004US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
09/07/2004US6787540 Compounds useful as reversible inhibitors of cysteine proteases
09/07/2004US6787534 Sulfonamide-containing heterocyclic compounds
09/02/2004WO2004074283A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
09/02/2004WO2004074280A1 Pyridine derivatives as fungicidal compounds
09/02/2004WO2004074274A1 Substituted n-aryl nitrogen heterocycles
09/02/2004WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
09/02/2004WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
09/02/2004WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
09/02/2004WO2004052313A3 Anti-infectives
09/02/2004WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
09/02/2004WO2004049797A3 Pesticidal sulphonylaminopyrazoles
09/02/2004WO2004035569A3 Novel compounds with antibacterial activity
09/02/2004WO2004014851A3 Tyrosine kinase inhibitors
09/02/2004WO2003099786A3 Aromatic sulfones and their medical use
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/02/2004US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS
09/02/2004US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
09/02/2004US20040171644 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
09/02/2004US20040171643 Acylaminothiazole derivatives, their preparation and therapeutic use
09/02/2004US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
09/02/2004US20040171638 Chemokine receptor binding heterocyclic compounds
09/02/2004US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus
09/02/2004US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials
09/02/2004US20040171614 Novel gamma secretase inhibitors
09/02/2004US20040171611 crystal modification of an active substance is important to the reproducible active substance content of a preparation
09/02/2004US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse.
09/02/2004US20040171604 strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses
09/02/2004US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds
09/02/2004US20040171520 Melanocortin receptor-specific peptidomimetics
09/02/2004US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture
09/02/2004US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations
09/02/2004US20040171075 Modulation of protein functionalities
09/02/2004DE10307845A1 Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclic amides, processes for their preparation, compositions containing them and their use as pesticides
09/02/2004DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles
09/02/2004CA2516590A1 Substituted n-aryl nitrogen heterocycles
09/02/2004CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
09/02/2004CA2516234A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
09/02/2004CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
09/01/2004EP1452530A1 Azole compound and medicinal use thereof
09/01/2004EP1452525A1 Amide derivatives and drugs
09/01/2004EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1452521A1 Cyclic compound and ppar agonist
09/01/2004EP1451185A1 Indole-2-carboxamides as factor xa inhibitors
09/01/2004EP1451175A1 Thrombin inhibitors
09/01/2004EP1451172A1 Therapeutic isoquinoline compounds
09/01/2004EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents
09/01/2004EP1451164A2 Amide derivatives having improved solubility
09/01/2004EP1451160A2 Pyrazole-amides and-sulfonamides
09/01/2004EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
09/01/2004EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
09/01/2004EP1451154A2 Inhibitors of cytosolic phospholipase a2
09/01/2004EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
09/01/2004EP1450801A2 2-aminoquinoline compounds
09/01/2004EP1450797A1 Benzothiazole derivatives
09/01/2004EP1450796A1 Benzothiazole derivatives
09/01/2004EP1450794A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
09/01/2004EP1450792A1 Benzazole derivatives for the treatment of scleroderma
09/01/2004EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics
09/01/2004EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
09/01/2004EP1292594B1 Quinazoline derivatives for the treatment of tumours
09/01/2004EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones
09/01/2004EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
09/01/2004EP0944623B1 Substituted pyrazole-3-yl benzazoles
09/01/2004CN1525971A Substituted benzo-nitro-heterocycles